Background: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Western countries, and strongly associated with type 2 diabetes mellitus (T2DM). Several studies have shown that hypoglycemic agents are effective for NAFLD combined with T2DM. However, there is still controversy over which hypoglycemic agent is the best for NAFLD combined with T2DM patients.
View Article and Find Full Text PDFInt J Syst Evol Microbiol
September 2017
Zhongguo Shi Yan Xue Ye Xue Za Zhi
June 2017
Int J Clin Exp Pathol
October 2016
Zhongguo Shi Yan Xue Ye Xue Za Zhi
April 2015
Zhonghua Fu Chan Ke Za Zhi
March 2013
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi
December 2011